#Pancreatic

Scientists have discovered how pancreatic cancer cells continually reshape their genetic makeup to become more aggressive, spread, and evade treatment.…

A phase 3 trial of daraxonrasib, an oral RAS(ON) inhibitor from Revolution Medicines, doubled median overall survival to 13.2 months versus 6.7 months with chemotherapy in previously treated metastatic pancreatic cancer.…

A daily oral medication demonstrates the ability to significantly extend survival in patients with one of oncology's most difficult-to-treat malignancies.

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, raising hopes that it may help to beat the deadly condition

From Independent RSS Feed: Breakthrough pancreatic cancer drug sparks huge patient demand at US clinics

People with a deadly form of pancreatic cancer survive longer on a drug that blocks the activity of a family of mutant proteins. People with a deadly form of pancreatic cancer survive longer on a drug that blocks the activity of a family of mutant…

A new AI tool finds early hints of pancreatic cancer in CT scans that doctors would otherwise miss, an early test found.

The AI identifies subtle signs of disease before tumors are visible on routine abdominal CT scans, the Mayo Clinic reports. The failure to find pancreatic cancer early makes it incredibly deadly,

From Independent RSS Feed: Promising drug found to double survival rate for advanced pancreatic cancer patients

Early trial data from Memorial Sloan Kettering suggests a personalised mRNA therapy can dramatically improve outcomes for some patients and extend lifespans.

Many are split on whether AI is good for humanity, but a new AI-powered tool could prove revolutionary when it comes to cancer screenings.

Plus, Cherie DeVaux becomes the first female trainer to win the Kentucky Derby, and a look at how AI can aid in diagnosing cancer.

From Independent RSS Feed: AI may be able to detect signs of pancreatic cancer before tumors are visible on scans, study suggests

Our fraught national debate over immunization and public health has overshadowed some extremely encouraging advances being made by researchers in the decades-long battle against cancer. Recent news of a potential […]

A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.

Trials for a pancreatic cancer mRNA vaccine: “Nearly 90% of people whose immune systems responded to the vaccine were still alive up to six years after receiving the last treatment. The five-year surv

1. Sindarov profile. And: “I know this GM who made 2600 at 19 without reading a chess book in his life.” And Magnus on Sindarov vs. Gukesh. 2. Inflation-adjusted book prices over time. 3. On the Amanat Iran book and its excellence. 4.…

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it.